Anti-Thrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC): Study design and methodology for an international, adaptive Bayesian randomized controlled trial
Brett L. Houston(CancerCare Manitoba), Ryan Zarychanski(CancerCare Manitoba), Scott Berry(Queen's University), Lindsay Bond, Patrick R. Lawler(McGill University Health Centre), Ewan C. Goligher(University Health Network), Arthur S. Slutsky(St. Michael's Hospital), Michael E. Farkouh(Cedars-Sinai Smidt Heart Institute), Mansoor Husain(Tawam Hospital), Marc Carrier(University of Ottawa), Srinivas Murthy, Dean Fergusson(Ottawa Hospital), Jorge Escobedo, Alexis F. Turgeon(Université Laval), John C. Marshall(University of Rochester), Susan R. Kahn(Jewish General Hospital), Charlotte Bradbury(University of Bristol), Anand Kumar(All India Institute of Medical Sciences), Robert Fowler(Sunnybrook Health Science Centre), Jean-Phillippe Galanaud(Sunnybrook Health Science Centre), Peter L. Gross(Thrombosis and Atherosclerosis Research Institute), Emily G. McDonald(McGill University Health Centre), Robert S Rosenson, Vlad Dzavik, José Carlos Nicolau(Hospital São Paulo), Sophie de Brouwer, Bridget‐Anne Kirwan
Cited by 68
Related Papers
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
|JAMA|2016|28.1k
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
|Intensive Care Medicine|2017|6.8k
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
|Critical Care Medicine|2003|6k